205 related articles for article (PubMed ID: 29024319)
1. Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Kang HS; Cho KW; Kwon SS; Kim YH
Respirology; 2018 Feb; 23(2):206-212. PubMed ID: 29024319
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
3. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Hachisu Y; Murata K; Takei K; Tsuchiya T; Tsurumaki H; Koga Y; Horie T; Takise A; Hisada T
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31086028
[No Abstract] [Full Text] [Related]
4. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
8. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202
[TBL] [Abstract][Full Text] [Related]
9. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis.
Rangappa P; Moran JL
Crit Care Resusc; 2009 Jun; 11(2):102-9. PubMed ID: 19485873
[TBL] [Abstract][Full Text] [Related]
11. Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis.
Sin S; Lee KH; Hur JH; Lee SH; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
PLoS One; 2018; 13(7):e0201154. PubMed ID: 30044866
[TBL] [Abstract][Full Text] [Related]
12. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
[TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
[TBL] [Abstract][Full Text] [Related]
14. The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
PLoS One; 2019; 14(8):e0212810. PubMed ID: 31425562
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-Based Prognostic Score Predicts Postoperative Survival of Patients with Interstitial Pneumonia After Undergoing Lung Cancer Resection.
Kobayashi S; Matsumura Y; Karube Y; Nishihira M; Inoue T; Araki O; Maeda S; Chida M
World J Surg; 2018 Jul; 42(7):2143-2152. PubMed ID: 29344688
[TBL] [Abstract][Full Text] [Related]
16. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
Teramachi R; Kondoh Y; Kataoka K; Taniguchi H; Matsuda T; Kimura T; Yokoyama T; Yamano Y; Furukawa T; Sakamoto K; Hashimoto N; Hasegawa Y
Respir Med; 2018 Oct; 143():147-152. PubMed ID: 30261987
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
18. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
Simon-Blancal V; Freynet O; Nunes H; Bouvry D; Naggara N; Brillet PY; Denis D; Cohen Y; Vincent F; Valeyre D; Naccache JM
Respiration; 2012; 83(1):28-35. PubMed ID: 21860222
[TBL] [Abstract][Full Text] [Related]
19. The Glasgow prognostic score as a significant predictor of clinical outcomes in patients with acute coronary syndrome.
Lee SN; Moon D; Moon KW; Yoo KD
J Cardiol; 2019 Aug; 74(2):130-135. PubMed ID: 30878352
[TBL] [Abstract][Full Text] [Related]
20. New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis.
Sakamoto S; Shimizu H; Isshiki T; Nakamura Y; Usui Y; Kurosaki A; Isobe K; Takai Y; Homma S
Sci Rep; 2022 Jan; 12(1):1134. PubMed ID: 35064161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
